Crossmark

Urinary exosomal RAB11A serves as a novel non-invasive biomarker for diagnosis, treatment response monitoring, and prognosis in small cell lung cancer

Crossref DOI link: https://doi.org/10.1186/s12014-025-09554-4

Published Online: 2025-08-25

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Weiwei

Liu, Na

Wang, Shanshan

Yu, Chunkai

Pan, Lei

Zhang, Man
Funding

Funding for this research was provided by:

Beijing Shijtan Hospital’s “14th Five-Year Plan” Leading Talent Training Project (2023LJRCPL)

the Beijing Key Laboratory of Urinary Cellular Molecular Diagnostics
License Information

Text and Data Mining valid from 2025-08-25

Version of Record valid from 2025-08-25
More Information

Article History

Received: 18 March 2025

Accepted: 4 August 2025

First Online: 25 August 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below